These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26667739)

  • 1. [COCONUT OIL: NON-ALTERNATIVE DRUG TREATMENT AGAINST ALZHEIMER´S DISEASE].
    Hu Yang I; De la Rubia Ortí JE; Selvi Sabater P; Sancho Castillo S; Rochina MJ; Manresa Ramón N; Montoya-Castilla I
    Nutr Hosp; 2015 Dec; 32(6):2822-7. PubMed ID: 26667739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How does coconut oil affect cognitive performance in alzheimer patients?].
    De la Rubia Ortí JE; Sánchez Álvarez C; Selvi Sabater P; Bueno Cayo AM; Sancho Castillo S; Rochina MJ; Hu Yang I
    Nutr Hosp; 2017 Mar; 34(2):352-356. PubMed ID: 28421789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study.
    de la Rubia Ortí JE; García-Pardo MP; Drehmer E; Sancho Cantus D; Julián Rochina M; Aguilar MA; Hu Yang I
    J Alzheimers Dis; 2018; 65(2):577-587. PubMed ID: 30056419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aromatherapy on patients with Alzheimer's disease.
    Jimbo D; Kimura Y; Taniguchi M; Inoue M; Urakami K
    Psychogeriatrics; 2009 Dec; 9(4):173-9. PubMed ID: 20377818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of functional food in cognitive deficit in young and senile rats.
    Attia HN; Ahmed KA
    Behav Pharmacol; 2020 Feb; 31(1):81-96. PubMed ID: 31923036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Brief Review of Caprylidene (Axona) and Coconut Oil as Alternative Fuels in the Fight Against Alzheimer's Disease.
    Chintapenta M; Spence J; Kwon HI; Blaszczyk AT
    Consult Pharm; 2017 Dec; 32(12):748-751. PubMed ID: 29467067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study.
    Ohnuma T; Toda A; Kimoto A; Takebayashi Y; Higashiyama R; Tagata Y; Ito M; Ota T; Shibata N; Arai H
    Clin Interv Aging; 2016; 11():29-36. PubMed ID: 26811674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
    Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
    Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action.
    Fernando WM; Martins IJ; Goozee KG; Brennan CS; Jayasena V; Martins RN
    Br J Nutr; 2015 Jul; 114(1):1-14. PubMed ID: 25997382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia.
    Kennedy J; Deberdt W; Siegal A; Micca J; Degenhardt E; Ahl J; Meyers A; Kaiser C; Baker RW
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1020-7. PubMed ID: 16250069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a community-based multidomain cognitive intervention program in patients with Alzheimer's disease.
    Kim HJ; Yang Y; Oh JG; Oh S; Choi H; Kim KH; Kim SH
    Geriatr Gerontol Int; 2016 Feb; 16(2):191-9. PubMed ID: 25656505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):113-22. PubMed ID: 12050474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer's Disease.
    Rigacci S
    Adv Exp Med Biol; 2015; 863():1-20. PubMed ID: 26092624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
    Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.